Cancer BiologybioRxiv
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
R. Soldi, T. Ghosh Halder, A. Weston…·S. Sharma
This study shows that the LSD1 inhibitor SP-2577 enhances anti-tumor immunity and PD-L1 expression in SWI/SNF-mutated ovarian cancer models.
DOI 10.1371/journal.pone.0235705